A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). (2016)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2015-309122
PubMed Identifier: 25765462
Publication URI: http://europepmc.org/abstract/MED/25765462
Type: Journal Article/Review
Volume: 65
Parent Publication: Gut
Issue: 1
ISSN: 0017-5749